Filing summary: Global Medical REIT Inc. 10-Q, first quarter 2023
Entity note: The supplied filing identifies the registrant as Global Medical REIT Inc. (NYSE: GMRE), not Chiron Real Estate Inc. This summary covers the filing provided.
Business context and reporting period
Global Medical REIT is an internally managed healthcare-property REIT that leases facilities primarily to physician groups and healthcare systems. The unaudited quarter ended March 31, 2023; comparisons are with the three months ended March 31, 2022, unless otherwise noted. At quarter-end, the portfolio comprised 188 buildings and approximately 4.9 million leasable square feet.
Key financial metrics
| Metric | Q1 2023 | Q1 2022 / comparison |
|---|---|---|
| Total revenue | $36.2 million | $31.9 million; up $4.4 million (13.7%) |
| Net income | $2.2 million | $4.3 million |
| Net income attributable to common stockholders | $0.7 million; $0.01 per share | $2.7 million; $0.04 per share |
| FFO per share and unit | $0.22 | $0.23 |
| AFFO per share and unit | $0.23 | $0.24 |
| Operating cash flow | $15.8 million | $16.4 million |
| Interest expense | $8.3 million | $4.8 million |
| Cash and restricted cash, March 31 | $14.0 million | $14.5 million at December 31, 2022 |
| Total debt, net, March 31 | $692.2 million | $694.1 million at December 31, 2022 |
| Total equity, including noncontrolling interest | $628.5 million | $649.1 million at December 31, 2022 |
Rental revenue was $36.2 million. The filing does not present a single operating-margin measure as a headline metric. The common dividend was $0.21 per share for the quarter; the Series A preferred dividend was $0.46875 per share. Total real estate investment, net of depreciation and amortization, was $1.27 billion.
Material changes versus the prior period
- Revenue grew mainly because of properties acquired after March 31, 2022 and a full quarter of revenue from certain 2022 acquisitions. Net lease expense recoveries increased to $5.2 million from $4.0 million.
- Expenses rose $7.0 million overall. Interest expense increased $3.5 million, reflecting higher average borrowings and higher rates; the weighted average debt rate for the quarter rose to 4.27% from 2.87%.
- Operating expenses increased $2.2 million, while depreciation and amortization increased by a combined $1.7 million. General and administrative expense declined $0.4 million.
- Net income fell to $2.2 million from $4.3 million; common-stockholder earnings declined to $0.01 per share from $0.04. FFO and AFFO per share/unit also decreased modestly.
- Operating cash flow was $15.8 million. Investing activities provided $3.1 million, including $4.2 million of net property-sale proceeds; financing activities used $19.3 million, including dividends and net credit-facility repayments.
- The company sold a Jacksonville medical office building in March for gross proceeds of approximately $4.4 million and recorded a $0.5 million gain. It made no acquisitions during the quarter.
Liquidity, debt, outlook, and risks
- At March 31, net borrowings under the credit facility were $634.8 million; notes payable were $57.4 million net. The facility includes a $400 million revolver. As of May 1, the company reported $244.5 million of unused revolver capacity.
- Management said the company was in compliance with its credit-facility financial and nonfinancial covenants at March 31. The weighted-average interest rate on debt was 4.28% at quarter-end. Interest-rate swaps hedge the term loans; $143.5 million of revolver borrowings remained unhedged.
- The filing estimates that a 100-basis-point increase in SOFR, with variable-rate debt unchanged, would increase annual interest expense by approximately $1.4 million. Management identifies higher rates, inflation, tenant rent collection and renewals, healthcare reimbursement changes, and tenant operating pressures as risks.
- The company reported approximately $29.2 million of aggregate capital-improvement commitments, with approximately $9.3 million expected in the next 12 months. It also disclosed a new headquarters lease commencing May 1, 2023, with approximately $7 million of total payments over its term.
- No formal earnings or operating guidance is provided. Management expects to meet liquidity needs through operating cash flow, debt and equity financing, property dispositions, and OP Units issued in acquisitions. It said higher interest rates and the company’s increased cost of capital have reduced its ability to pursue acquisitions meeting its investment requirements.
- Pipeline Health System, tenant at the company’s White Rock Medical Center, filed for Chapter 11 in 2022. Its reorganization plan became effective February 6, 2023, and Pipeline assumed the leases with amendments. No material litigation or environmental liability was reported.
- After quarter-end, through May 1, the company completed one acquisition for $6.7 million, with $6.3 million of OP Units issued as partial consideration. The property had annualized base rent of $0.5 million.
Most important facts for investors to verify
- Confirm the registrant and ticker: the supplied filing is Global Medical REIT Inc. (GMRE), despite the request metadata naming Chiron Real Estate Inc.
- Review interest-rate exposure, hedge maturities, revolver availability, debt maturities, and ongoing compliance with credit covenants.
- Assess whether rental collections and tenant credit remain sound, including the amended White Rock leases following Pipeline’s bankruptcy.
- Compare recurring cash generation and dividend requirements: Q1 operating cash flow was $15.8 million, while common and preferred dividends were paid.
- Evaluate planned capital improvements, the post-quarter acquisition, and the effect of higher financing costs on acquisition capacity and returns.
- Consider that FFO and AFFO are non-GAAP measures and should be reviewed alongside GAAP earnings and cash flows.